SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-21-007313
Filing Date
2021-08-11
Accepted
2021-08-11 09:46:28
Documents
15
Period of Report
2021-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 17320
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 83550
  Complete submission text file 0001062993-21-007313.txt   329292

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20210811.xsd EX-101.SCH 4385
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20210811_cal.xml EX-101.CAL 694
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20210811_def.xml EX-101.DEF 21318
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20210811_lab.xml EX-101.LAB 44284
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20210811_pre.xml EX-101.PRE 23761
8 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 2683
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

IRS No.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31187 | Film No.: 211162249
SIC: 2834 Pharmaceutical Preparations